Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
Michael A Nauck Department of Internal Medicine, Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany Abstract: The importance of the kidney's role in glucose homeostasis has gained wider understanding in recent years. Consequently, the development of a new pharmacological class...
Main Author: | Nauck MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/update-on-developments-with-sglt2-inhibitors-in-the-management-of-type-peer-reviewed-article-DDDT |
Similar Items
-
Sglt2 Inhibitors – Is the Paradigm in Type 2 Diabetes Mellitus Management Changing ?
by: Serafinceanu Cristian, et al.
Published: (2014-12-01) -
SGLT2 Inhibitors: the Star in the Treatment of Type 2 Diabetes?
by: Yoshifumi Saisho
Published: (2020-05-01) -
New SGLT2 inhibitor ertugliflozin: safe and effective in the management of type 2 diabetes
by: V. V. Salukho, et al.
Published: (2020-05-01) -
Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
by: Leyna Leite Santos, et al. -
SGLT-2 inhibitors and their potential in the treatment of diabetes
by: Rosenwasser RF, et al.
Published: (2013-11-01)